Annual EBITDA
-$1.26B$158.51M-14.33%
Summary
- Current Value
- As of today, ROIV annual EBITDA is -$1.26B, down -14.33% on
- Historical Performance
- ROIV annual EBITDA is down -20.33% over the past 3 years, down -41.21% over the past 5 years
- All-Time High Comparison
- ROIV annual EBITDA is currently -55.32% below its historical high of -$814.35M set on
- 3-Year Low Comparison
- ROIV annual EBITDA is at its 3-year low
- Sector Comparison
- ROIV annual EBITDA is higher than 0.26% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$1.26B | -14.3% | -20.3% | -41.2% | – | |
| Quarterly EBITDA | -$354.36M | -25.0% | -56.3% | +3.1% | – | |
| TTM EBITDA | -$1.28B | -15.9% | -21.2% | -250.6% | – | |
| Price | $29.05 | +162.2% | +189.6% | +192.4% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $8.26M | -71.6% | -86.5% | -65.3% | +255.4% | |
| Annual EPS | -$0.43 | -82.2% | +69.5% | +88.1% | +91.1% | |
| -$1.27B | -13.9% | -17.7% | -18.4% | -69.4% | ||
| Annual Net Income | -$397.91M | +45.5% | +67.7% | +55.8% | +50.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$814.35M | -55.3% | |
| 5Y | -$814.35M | -55.3% | |
| All | -$814.35M | -55.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$1.26B | at low | |
| 5Y | -$1.26B | at low | |
| All | -$1.26B | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$1.26B | -14.3% | |
| -$1.11B | -35.9% | |
| -$814.35M | +22.5% |
| Year | Value | Change |
|---|---|---|
| -$1.05B | -15.4% | |
| -$910.77M | -1.7% | |
| -$895.74M | - |
FAQ
What is the current annual EBITDA of ROIV?
As of today, ROIV annual EBITDA is -$1.26B
What is 1-year change in ROIV annual EBITDA?
ROIV annual EBITDA is down -14.33% year-over-year
What is 3-year change in ROIV annual EBITDA?
ROIV annual EBITDA is down -20.33% over the past 3 years
How far is ROIV annual EBITDA from its all-time high?
ROIV annual EBITDA is currently -55.32% below its historical high of -$814.35M set on March 31, 2024
How does ROIV annual EBITDA rank versus sector peers?
ROIV annual EBITDA is higher than 0.26% of companies in Healthcare sector
When is ROIV next annual earnings release?
As of today, the next annual earnings release for ROIV has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$354.36M$15.90M-4.70%
Summary
- Current Value
- As of today, ROIV quarterly EBITDA is -$354.36M, down -4.70% on
- Historical Performance
- ROIV quarterly EBITDA is down -24.96% year-over-year, down -56.34% over the past 3 years
- All-Time High Comparison
- ROIV quarterly EBITDA is currently -183.03% below its historical high of -$125.20M set on
- 3-Year Low Comparison
- ROIV quarterly EBITDA is at its 3-year low
- Sector Comparison
- ROIV quarterly EBITDA is higher than 0.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$354.36M | -4.7% | -25.0% | -56.3% | +3.1% | |
| Annual EBITDA | -$1.26B | – | -14.3% | -20.3% | -41.2% | |
| TTM EBITDA | -$1.28B | -5.8% | -15.9% | -21.2% | -250.6% | |
| Price | $29.05 | -1.6% | +162.2% | +189.6% | +192.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $2.52M | +26.1% | -66.7% | -90.8% | -83.4% | |
| Quarterly EPS | $0.37 | +197.8% | +227.8% | +923.4% | +116.3% | |
| -$355.00M | -4.7% | -24.6% | -51.6% | +34.4% | ||
| Quarterly Net Income | $355.74M | +213.4% | +241.0% | +302.8% | +163.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$283.58M | N/A | -25.0% |
| 3Y | -$201.68M | -75.7% | |
| 5Y | -$125.20M | -183.0% | |
| All | -$125.20M | -183.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$354.36M | at low | |
| 3Y | -$354.36M | at low | |
| 5Y | -$684.43M | +48.2% | |
| All | -$684.43M | +48.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ROIV?
As of today, ROIV quarterly EBITDA is -$354.36M
What is ROIV quarterly EBITDA most recent change?
ROIV quarterly EBITDA was down -4.70% on March 31, 2026
What is 1-year change in ROIV quarterly EBITDA?
ROIV quarterly EBITDA is down -24.96% year-over-year
How far is ROIV quarterly EBITDA from its all-time high?
ROIV quarterly EBITDA is currently -183.03% below its historical high of -$125.20M set on March 31, 2022
How does ROIV quarterly EBITDA rank versus sector peers?
ROIV quarterly EBITDA is higher than 0.46% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$1.28B$70.78M-5.84%
Summary
- Current Value
- As of today, ROIV TTM EBITDA is -$1.28B, down -5.84% on
- Historical Performance
- ROIV TTM EBITDA is down -15.87% year-over-year, down -21.17% over the past 3 years
- All-Time High Comparison
- ROIV TTM EBITDA is currently -250.57% below its historical high of -$365.67M set on
- 3-Year Low Comparison
- ROIV TTM EBITDA is at its 3-year low
- Sector Comparison
- ROIV TTM EBITDA is higher than 0.37% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$1.28B | -5.8% | -15.9% | -21.2% | -250.6% | |
| Annual EBITDA | -$1.26B | – | -14.3% | -20.3% | -41.2% | |
| Quarterly EBITDA | -$354.36M | -4.7% | -25.0% | -56.3% | +3.1% | |
| Price | $29.05 | -1.6% | +162.2% | +189.6% | +192.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $8.26M | -37.9% | -71.6% | -86.5% | -45.5% | |
| TTM EPS | -$0.50 | +56.9% | -102.6% | +64.8% | +78.0% | |
| -$1.29B | -5.8% | -15.4% | -19.3% | -137.7% | ||
| TTM Net Income | -$397.91M | +60.5% | +45.5% | +67.7% | +29.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.11B | N/A | -15.9% |
| 3Y | -$832.64M | -54.0% | |
| 5Y | -$365.67M | N/A | -250.6% |
| All | -$365.67M | -250.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.28B | at low | |
| 3Y | -$1.28B | at low | |
| 5Y | -$1.45B | +11.5% | |
| All | -$1.45B | +11.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ROIV?
As of today, ROIV TTM EBITDA is -$1.28B
What is ROIV TTM EBITDA most recent change?
ROIV TTM EBITDA was down -5.84% on March 31, 2026
What is 1-year change in ROIV TTM EBITDA?
ROIV TTM EBITDA is down -15.87% year-over-year
How far is ROIV TTM EBITDA from its all-time high?
ROIV TTM EBITDA is currently -250.57% below its historical high of -$365.67M set on March 31, 2021
How does ROIV TTM EBITDA rank versus sector peers?
ROIV TTM EBITDA is higher than 0.37% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ROIV Official Website roivant.com
- ROIV Profile on Yahoo Finance finance.yahoo.com/quote/ROIV
- ROIV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/roiv